Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
Applying to National Institutes of Health Clinical Center · Bethesda, Maryland
Answer a few short questions to share with the research team.